| 000 | 01347 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513060816.0 | ||
| 264 | 0 | _c19941010 | |
| 008 | 199410s 0 0 eng d | ||
| 022 | _a0022-3069 | ||
| 024 | 7 |
_a10.1097/00005072-199409000-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoses, A D | |
| 245 | 0 | 0 |
_aApolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. _h[electronic resource] |
| 260 |
_bJournal of neuropathology and experimental neurology _cSep 1994 |
||
| 300 |
_a429-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xmetabolism |
| 650 | 0 | 4 |
_aAmyloid _xphysiology |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
| 650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xgenetics |
| 650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsomerism |
| 650 | 0 | 4 | _aModels, Neurological |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aTime Factors |
| 773 | 0 |
_tJournal of neuropathology and experimental neurology _gvol. 53 _gno. 5 _gp. 429-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005072-199409000-00002 _zAvailable from publisher's website |
| 999 |
_c8083010 _d8083010 |
||